Omicron Variant Directly Penetrates The CNS Via The Olfactory Bulb, Causing Inflammation And Neuronal Damage!
Nikhil Prasad Fact checked by:Thailand Medical News Team Mar 13, 2024 1 month, 2 weeks, 4 hours, 54 minutes ago
COVID-19 News: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has not only affected the respiratory system but has also unveiled its propensity to invade the central nervous system (CNS), leading to a myriad of neurological complications. This phenomenon, termed Neuro-COVID, has garnered increasing attention due to its diverse manifestations, ranging from mild symptoms like anosmia and headache to severe conditions such as encephalitis and stroke. While initially considered rare, the incidence of Neuro-COVID has surged, particularly with the emergence of new variants such as Omicron. Understanding the mechanisms underlying SARS-CoV-2 neuroinvasion is crucial for devising effective management strategies and mitigating long-term neurological sequelae.
Omicron Variant Directly Penetrates The CNS Images of brain MRI scans of Neuro-COVID patients. (A and B) A 20-year-old woman presented with gradually worsening delirium after an upper respiratory tract infection. MR imaging of the brain demonstrated prominent T2-FLAIR abnormalities in the splenium of the corpus callosum (Arrowheads). (C and D) A 55-year-old man with recurrent acute myelitis presented with progressively worsening numbness and weakness in the extremities. Contrast-enhanced MRI of the cervical and thoracic spine exhibited abnormal enhancement of the cervical spinal cord and enhancement of the cervicothoracic meninges (Arrowheads). (E and F) A 19-year-old man presented with psychosis and behavior disorder. MRI of the brain prominent T2-FLAIR abnormalities in the bilateral hippocampus
In a past
COVID-19 News coverage dated 19
th December 2021, Thailand Medical News had already warned that the Omicron variant and its subsequent sub-lineages are more neuroinvasive.
https://www.thailandmedical.news/news/good-news-preliminary-unpublished-data-shows-that-omicron-might-not-affect-lungs-much,-rather-your-brains,-heart-and-other-organs-are-targets
The Emergence of Neuro-COVID: Insights from Clinical Findings
Historically, Neuro-COVID was considered uncommon, with a reported incidence of around 3.5% for severe neurological events in 2020. However, the landscape changed dramatically with the widespread transmission of COVID-19, particularly in regions like China, where a surge in cases was observed, including a notable increase in Neuro-COVID patients. Contrary to initial beliefs that neurological manifestations were primarily driven by hyperimmune responses and cytokine release syndrome (CRS), recent evidence suggests direct invasion of the CNS by SARS-CoV-2, especially with the emergence of variants like Omicron.
The Omicron Variant: A Shift in Neurotropism and Pathogenesis
>
Omicron, characterized by heightened neurotropism, presents a paradigm shift in the understanding of SARS-CoV-2 neuroinvasion. Unlike previous variants, Omicron demonstrates an increased ability to penetrate the CNS through the olfactory bulb, bypassing traditional barriers. This direct invasion triggers neuroinflammation and neuronal damage, contributing to the onset of acute neurological syndromes early in infection. The unique pathogenesis of Omicron underscores the urgency of vigilance regarding potential neurological complications associated with COVID-19.
Unveiling SARS-CoV-2 Invasion in the CNS: Insights
A groundbreaking multicenter study documented the definitive presence of SARS-CoV-2 in the cerebrospinal fluid (CSF) of Neuro-COVID patients. This revelation challenged previous notions of limited CNS invasion and highlighted the need for ongoing research to elucidate the virus's enduring effects on neurological health.
Notable differences were observed between RNA-CSF-positive and negative patients, including variations in blood-brain barrier integrity, extent of neuronal damage, and inflammatory activation status. These findings underscored the intricate interplay between SARS-CoV-2 and the CNS, emphasizing the necessity for comprehensive investigation into Neuro-COVID.
Clinical Disparities and CSF Analysis: Unraveling the Neurological Impact
Detailed analysis of clinical disparities between RNACSF-positive and negative patients revealed significant differences in neurological presentations, time from COVID-19 confirmation to symptom onset, and recurrence probability of preexisting neurological disorders. Furthermore, CSF analysis provided valuable insights into SARS-CoV-2 invasion in the CNS, with the detection of intact viral particles and specific antigens and antibodies serving as crucial evidence. Additionally, comparison with patients diagnosed with viral encephalitis (VE) highlighted distinct neurologic damage and immune response patterns in Neuro-COVID patients.
Key Findings in Neuro-COVID Patients: Implications for Understanding Pathogenesis
The study identified key findings in the CSF of Neuro-COVID patients, shedding light on neurologic damage, blood-brain barrier integrity, and immune response dynamics. While RNACSF-positive patients exhibited pronounced neuronal damage, RNACSF-negative patients displayed higher CSF total protein concentrations and increased rates of positive oligoclonal bands, suggesting potential differences in BBB integrity. Furthermore, analysis of cytokine levels in the CSF highlighted a less intense immune response in Neuro-COVID patients compared to those with VE, underscoring the unique nature of SARS-CoV-2 neuroinvasion.
Neuro-Specific Autoantibodies: Insights into Autoimmune Responses
Detection of neuro-specific autoantibodies in Neuro-COVID patients provided valuable insights into autoimmune responses triggered by SARS-CoV-2 infection in the CNS. Identification of NMDA receptor and GFAP antibodies underscored the link between SARS-CoV-2 infections, CNS invasion, and autoimmune encephalitis. The differential diagnosis and treatment response in patients with neuro-specific autoantibodies highlighted the nuanced nature of autoimmune responses post-SARS-CoV-2 infection, emphasizing the need for personalized treatment strategies.
Conclusion
The evolving landscape of Neuro-COVID, particularly with the emergence of variants like Omicron, underscores the complex interplay between SARS-CoV-2 and the CNS. Multicenter studies have provided critical insights into SARS-CoV-2 neuroinvasion, clinical disparities, CSF analysis, and autoimmune responses, enhancing our understanding of Neuro-COVID pathogenesis. These findings have significant implications for devising effective management strategies and guiding future research endeavors aimed at unraveling the complexities of Neuro-COVID. As the pandemic continues to evolve, comprehensive investigation into the neurological impact of SARS-CoV-2 remains paramount in safeguarding neurological health and mitigating long-term sequelae associated with COVID-19.
The study findings were published in the peer reviewed journal: MedComm (Wiley).
https://onlinelibrary.wiley.com/doi/10.1002/mco2.508
For the latest
COVID-19 News, keep on logging to Thailand Medical News.
Read Also:
https://www.thailandmedical.news/news/covid-19-news-australian-study-shows-that-sars-cov-2-omicron-ba-5-and-xbb-variants-have-increased-neurotropic-potential-over-ba-1
https://www.thailandmedical.news/news/breaking-covid-19-news-university-of-queensland-study-shockingly-finds-that-ba-5-sub-lineages-are-more-neurovirulent-that-earlier-omicron-variants
https://www.thailandmedical.news/news/breaking-sars-cov-2-ba-5-variant-could-be-more-neuropathogenic-urgent-studies-warranted-to-assess-long-covid-threats-to-the-brain-and-cns
Share
Tweet
Share
